|
 |
|
| |
|
Newsletter Sponsor
|
|
Construction Underway for Second $8M Pilot Plant
Alphora is pleased to announce its expansion of plant operations will come online mid-2017. This will double the size of the plant operations, adding 500L, 200L and 50L vessels.
The addition will complement existing operations, providing additional capacity for new business and redundancy to support commercial programs.
Alphora provides API Technology Development and scale-up services for complex small molecules, including niche API’s, high potency and cytotoxic compounds. Our services cover IND enabling development, phase II & III, and commercial manufacturing
 |
|
|
|
|
|
|
|
|
|
 |
Featured Articles |
 |
|
| |
Meeting Current and Future Serialization Challenges
Meeting Current and Future Serialization Challenges
Serialization has emerged as a complex challenge for the pharmaceuticals sector. The industry is currently facing a multiplicity of differing regulations governing serialization that vary from one ...
read more » |
 |
|
|
|
|
|
 |
| |
|
|
|
|
Featured Whitepapers & Application Notes |
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
Events |
|
|
| |
|
|
DCAT Week ‘17
New York, NY – 03/20/2017
DCAT Week is the premier business development event for companies engaged in and supporting pharmaceutical development and manufacturing. Its unique ...
event details » |
|
|
|
|
|
INTERPHEX
New York, NY – 03/21/2017
All of the Solutions you need to Cost Effectively Develop and Manufacture Quality Product. INTERPHEX is THE pharma, bio and device development/...
event details » |
|
|
|
 |
|
|
|
